Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine;Ausprägung, stabilität und muster kognitiver und nicht kognitiver symptome bei patienten mit Alzheimer-Demenz: Verlaufsbeobachtungen über zwei jahre unter konstanten behandlungsbedingungen mit rivastigmin

Fortschritte der Neurologie Psychiatrie

Volumn 71, Issue 4, 2003, Pages 199-204

  Wobrock, T ^a   Retz Junginger, P ^a   Retz, W ^a   Supprian, T ^a   Rosler M ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; RIVASTIGMINE;

ADULT; AGED; AGGRESSION; ALZHEIMER DISEASE; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; DELUSION; DETERIORATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HALLUCINATION; HUMAN; MALE; MOOD DISORDER; PSYCHOSIS; SYMPTOMATOLOGY;

AFFECTIVE DISORDERS, PSYCHOTIC; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANXIETY DISORDERS; CARBAMATES; CHOLINESTERASE INHIBITORS; COGNITION; DISEASE PROGRESSION; FEMALE; HALLUCINATIONS; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; PHENYLCARBAMATES; PSYCHIATRIC STATUS RATING SCALES;

EID: 0344405777     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-38509     Document Type: Article

References (42)

1. Guo Z, Fratiglioni L, Zhu L, Fastbom J, Winblad B, Viitanen M. Occurrence and Progression of Dementia in a Community Population Aged 75 Years and Older. Arch Neurol 1999; 56: 991-996
2. Wernicke TF, Reischies FM. Prevalence of dementia in old age: Clinical diagnosis in subjects aged 95 years and older. Neurology 1994; 44: 250-253
3. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996; 46: 130-135
4. Drevets WC, Rubin EH. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol Psychiatry 1989; 25: 39-48
5. Rosen J, Zubenko GS. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biol Psychiatry 1991; 29: 224-232
6. Haupt M, Romero B, Kurz A. Delusions and hallucinations in Alzheimer's disease: results from a two-year longitudinal study. Int J Geriatr Psychiat 1996; 11: 965-972
7. Devanand DP, Jacobs DM, Tang MX, Del Castillo-Castaneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y. The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry 1997; 54: 257-263
8. Haupt M, Jänner M, Ebeling S, Stierstorfer A, Kretschmar C. Presentation and stability of noncognitive symptom patterns in patients with Alzheimer's disease. Alz Dis Ass Dis 1998; 12: 323-329
9. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990; 147: 1049-1051
10. Haupt M, Kurz A. Predictors of nursing home placement in patients with Alzheimer's disease. Int J Geriatr Psychiat 1993; 8: 741-746
11. Knapp MJ, Knopman DS, Solomon PR. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271: 985-991
12. Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Möller HJ, Rogers SL, Friedhoff LT. The effects of donezepil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord 1999; 10: 237-244
13. Rösler M, Anand R, Cicin-Sain A, Gauthier S, Agid Y, Dal-Bianco P, Stähelin HB, Hartman R, Gharabawi M and B303 Exelon Study Group. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ 1999; 318: 633-638
14. Wilcock GK, Lilienfeld S, Gaens E. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. BMJ 2000; 321: 1-7
15. Kaufer D, Cummings JL, Christine D, Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity. Neuropsychiatry Clin Neurosci 1998; 10: 55-63
16. Rösler M, Retz W, Retz-Junginger P, Dennler HJ. Effects of two-year treatment with the cholinesterase inhibitor rivastigmine on behavioural symptoms in Alzheimer's disease. Behav Neurology 1998/1999; 11: 211-216
17. Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, Wetterholm AL, Zhang R, Haglund A, Subbiah P. A 1-year, randomised, placebo-controlled study of donezepil in patients with mild to moderate AD. Neurology 2001; 57: 489-495
18. Mc Khann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 936-944
19. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12: 1-22
20. Mohs RC, Rosen WG, Davis KL Defining treatment efficacy in patient with Alzheimer's disease: A report of progress in research. Edited by Corkin S, Davis KL, Growdon JH et al. New York: Raven Press, 1982
21. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48 (Suppl. 5): 9-15
22. Reisberg B, Ferris S, de Leon M, Crook T. Global Deterioration Scale (GDS). Psychopharmacol Bull 1988; 24: 661-663
23. Birkett DP. The psychiatric differentation of senility and arteriosclerosis. Br J Psychiatry 1972; 120: 321-325
24. Leuchter AF, Spar JE. The late onset psychoses. J Nerv Ment Disord 1985; 173: 488-494
25. Ballard C, Oyebode F. Psychotic symptoms in patients with dementia. Int J Geriatr Psychiat 1995; 10: 743-752
26. Cummings JL, Miller B, Hill MA, Neshres R. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer-type. Arch Neurol 1987; 44: 389-393
27. Rabins PV, Mace NL, Lucas MJ. The impact of dementia on the family. J Am Med Assoc 1982; 248: 333-335
28. Wragg R, Jeste D. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1988; 146: 577-587
29. Gormley N, Rizwan MR, Lovestone S. Clinical predictors of aggressive behaviour in Alzheimer's disease. Int J Geriatr Psychiat 1998; 13: 109-115
30. Keene J, Hope T, Fairburn CG, Jacoby R, Gedling K, Ware CJG. Natural history of aggressive behaviour in dementia. Int J Geriat Psychiatry 1999; 14: 541-548
31. Borson S, Raskind MA. Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease. Neurology 1997; 48 (Suppl. 6): S17-S24
32. Farlow M, Anand R, Messina Jr J, Hartmann R, Veach J. A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. Eur Neurol 2000; 44: 236-241
33. Rogers SL, Friedhoff LT. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the result of a US multicentre open label extension study. Eur Neuropsychopharmacol 1998; 8: 67-75
34. Weiner MF, Martin-Cock K, Forster BM, Saine K, Fontaine CS, Svetlik DA. Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients. J Clin Psychiatry 2000; 61: 487-492
35. Rösler M. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Int J Clin Pract 2002; Supplement 127: 20-36
36. Migliorelli E, Teson A, Sabe L, Petracchi M, Leiguarda R, Starkstein SE. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am J Psychiatry 1995; 152: 37-44
37. Haupt M, Kurz A, Jänner M. A 2-year follow-up of behavioural and psychological symptoms in Alzheimer's disease. Dement Geriatr Cogn Disord 2000; 11: 147-152
38. Hope T, Keene J, Fairburn CG, Jacoby R, McShane R. Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. Br J Psychiatry 1999; 174: 39-44
39. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. 11: Disorders of perception. Br J Psychiatry 1990; 157: 76-81
40. Förstl H, Besthorn C, Geiger-Kabisch C, Sattel H, Schreiter-Gasser U. Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findings. Acta Psychiatr Scand 1993; 87: 395-399
41. Patel V, Hope T. Aggessive behaviour in elderly people with dementia: a review. Int J Geriatr Psychiatry 1993; 8: 457-472
42. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour. Br J Psychiatry 1990; 157: 86-94